DEF 14A: Advent Technologies Seeks Capital, Expands Incentive Plan
Proxy Statement
Advent Technologies Holdings, Inc. will hold its 2025 Annual Meeting to elect directors, ratify auditors, approve a potential $52 million stock issuance, and amend its incentive plan.
Summary
- The 2025 Annual Meeting of Stockholders will be held virtually on October 22, 2025, at 9:00 a.m. Eastern Time.
- Stockholders will vote on the election of three Class II directors to serve until the 2027 annual meeting.
- A proposal seeks to ratify the appointment of M&K CPAS, PLLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Approval is sought for the potential issuance and sale of 20% or more of Common Stock to Hudson Global Ventures, LLC, for up to $52,000,000, to comply with Nasdaq Listing Rule 5635(d).
- An amendment to the 2021 Incentive Plan is proposed to increase the number of shares of Common Stock issuable from 569,306 to 1,011,627 and to incorporate an 'Evergreen Provision' for annual increases (lesser of 3% of outstanding shares or Board-determined smaller number) from January 1, 2027, to January 1, 2046.
- Non-binding advisory votes will be conducted on the compensation of named executive officers and the preferred frequency (Board recommends every three years) for such votes.
- Stockholders will also vote on transacting other business and approving any adjournments or postponements of the meeting.
- As of the Record Date, September 19, 2025, there were 3,291,634 shares of Common Stock issued and outstanding.
- The company has already issued 490,000 shares of Common Stock to Hudson Global under the Purchase Agreement as of the proxy statement date.
- Executive officers elected to forgo compensation payments beginning June 2024, with such deferred compensation reflected as an accrued liability.
- The company reported net losses of $40,994 in 2024, $71,397 in 2023, and $74,337 in 2022.
Sentiment
Score: 3
Explanation: The filing outlines necessary corporate governance actions and a significant capital raise opportunity, which are positive for continuity. However, the company's ongoing net losses, lack of gross profit, and the need for substantial dilution to raise capital, coupled with executive compensation deferrals and a termination for cause, indicate significant operational and financial challenges.
Positives
- The company is seeking approval for a potential capital raise of up to $52,000,000 from Hudson Global Ventures, LLC, which could provide crucial working capital and support general corporate purposes.
- The proposed amendment to the 2021 Incentive Plan, increasing authorized shares to 1,011,627 and adding an Evergreen Provision, aims to attract, retain, and motivate highly-qualified employees and non-employee directors.
- The Board recommends 'FOR' all key proposals, including the capital raise and incentive plan amendment, indicating unified management support.
- The company maintains meaningful stock ownership guidelines for executives and non-employee directors, reinforcing alignment of interests with stockholders.
- A comprehensive insider trading policy prohibits pledging or hedging company securities, promoting long-term alignment with stockholder interests.
Negatives
- The potential issuance and sale of 20% or more of Common Stock to Hudson Global Ventures, LLC, will result in significant dilution to existing stockholders and may lead to a decline in stock price or greater price volatility.
- Executive officers elected to forgo compensation payments beginning June 2024, with deferred compensation reflected as an accrued liability, suggesting potential liquidity or cash flow challenges.
- The company reported substantial net losses: $40,994 in 2024, $71,397 in 2023, and $74,337 in 2022.
- Vassilios Gregoriou, former Chairman and CEO, was terminated for cause on October 24, 2024, leading to the forfeiture of vested and unvested equity awards.
- Several directors (Messrs. Lukash, Celia, Dhaliwal, Schwartz, and Seelenfreund) did not timely file one Form 3 for fiscal year 2024, indicating Section 16(a) reporting delinquencies.
- The compensation committee explicitly stated that the company 'has not generated any gross profit,' highlighting fundamental operational challenges.
Risks
- Significant dilution to existing stockholders from the potential issuance of 20% or more of Common Stock to Hudson Global Ventures, LLC.
- Potential decline in stock price or greater price volatility due to the increased share count from the Hudson Global transaction.
- Failure to obtain stockholder approval for the Hudson Global transaction (Proposal 3) would prevent the company from issuing shares in excess of the Nasdaq 20% Rule at a price less than the minimum price, limiting access to capital.
- Failure to obtain stockholder approval for the Incentive Plan Amendment (Proposal 4) could hinder the company's ability to attract, retain, and motivate key talent through equity compensation.
- The company operates in a dynamic and rapidly evolving environment, requiring a highly-skilled and technical workforce, which presents ongoing challenges in talent acquisition and retention.
- The company has not generated any gross profit, indicating persistent operational challenges and a continued reliance on external financing.
- The exercise of an Incentive Stock Option (ISO) may result in an alternative minimum tax liability to the participant.
- Non-qualified deferred compensation under a plan that fails to satisfy certain requirements of Section 409A of the Code could subject a participant to additional taxes and interest.
Future Outlook
The company intends to use the net proceeds from the potential $52,000,000 stock issuance to Hudson Global Ventures, LLC, for working capital and general corporate purposes. The proposed amendment to the 2021 Incentive Plan is designed to support compensation goals and enhance the company's ability to attract, retain, and motivate highly-qualified employees and non-employee directors over the next several years. The company expects to continue operating in a dynamic and rapidly evolving environment.
Management Comments
- We are pleased to notify you that Advent Technologies Holdings, Inc. will hold the 2025 annual meeting of our stockholders.
- We look forward to seeing you at the Annual Meeting.
- Our board of directors and compensation committee believe that these policies and practices are effective in implementing the Company’s compensation philosophy and in achieving the Company’s compensation program goals.
- Our board of directors believes that holding an advisory vote on the compensation of our named executive officers every three years is the most appropriate policy at this time.
- While we are required by SEC rules to disclose the relationship between our net income and Compensation Actually Paid to our NEOs, this is not a metric our compensation committee currently uses in evaluating our NEOs compensation as we are a company that has not generated any gross profit.
Industry Context
The company operates in a dynamic and rapidly evolving environment, requiring a highly-skilled and technical workforce. The expertise of its directors and officers spans the telecom and cellular arena, technology and manufacturing, and specifically fuel cell materials, catalysts, electrochemical technology, and HT PEM MEA development, indicating a focus on the fuel cell and clean energy sector. The mention of 'GreenHiPo' ratification by the European Union suggests involvement in European clean energy initiatives.
Comparison to Industry Standards
- The company elected to forgo establishing a compensation peer group in 2024, instead relying on general survey data for benchmark purposes, scoped to the company's size, which deviates from a common practice of using specific peer comparisons.
- The company has not generated any gross profit, which is a significant underperformance compared to established industry standards for mature companies and indicates fundamental challenges in its business model or market penetration.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer, Interim Chief Financial Officer | Vassilios Gregoriou | Gary Herman | October 2024 | Vassilios Gregoriou terminated for cause. |
| Director | N/A | Gary Herman | August 2024 | Appointment to the Board. |
| Chairman of the Board of Directors, Chief Executive Officer, Acting Chief Financial Officer | Vassilios Gregoriou | N/A | 2024-10-24 | Termination for cause. |
| Non-Employee Director | Anggelos Skutaris | N/A | 2024-08-30 | No longer serving on the board of directors. |
| Non-Employee Director | Lawrence Epstein | N/A | 2024-08-30 | No longer serving on the board of directors. |
| Non-Employee Director | Wayne Threatt | N/A | 2024-08-30 | No longer serving on the board of directors. |
| Non-Employee Director | Von McConnell | N/A | 2024-08-30 | No longer serving on the board of directors. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Structure | The Board is divided into three classes (I, II, III) with staggered twoor three-year terms. Class II directors (Messrs. Seelenfreund, Lukash, and Celia) are up for re-election for terms expiring at the 2027 annual meeting. Class III directors (Dr. De Castro and Mr. Herman) will be up for re-election at the 2026 annual meeting, and the Class I director (Mr. Schwartz) at the 2027 annual meeting. | N/A | This staggered board structure may delay or prevent a change of management or a change in control of the company. |
| Director Independence | Four out of six board members (Messrs. Lukash, Celia, Schwartz, and Seelenfreund) are determined to be independent directors in accordance with Nasdaq listing requirements and Exchange Act rules. Dr. De Castro and Mr. Herman are not independent due to their executive roles. | N/A | Ensures compliance with Nasdaq rules for board and committee independence, promoting objective oversight. |
| Risk Oversight | The Board actively oversees the management of company risks, both as a whole and through its audit, compensation, and nominating and corporate governance committees, which are responsible for specific risk areas. | N/A | Provides a structured approach to identifying, evaluating, and managing various corporate risks, including financial, operational, and governance risks. |
| Committee Composition | The Audit Committee consists of Messrs. Lukash (chair), Celia, and Seelenfreund (all independent, with Mr. Lukash qualifying as a financial expert). The Compensation Committee consists of Messrs. Lukash and Celia (Mr. Celia is chair). The Nominating and Corporate Governance Committee consists of Messrs. Lukash (chair) and Celia (both independent). | N/A | Ensures specialized oversight for financial reporting, executive compensation, and board nominations, with independent members leading key functions. |
| Compensation Consultant Engagement | The compensation committee engaged ClearBridge Compensation Group LLC as its independent compensation consultant for 2024, relying on survey data for benchmark purposes rather than a specific peer group. | N/A | Provides independent expertise for executive compensation decisions, though the absence of a specific peer group in 2024 might limit direct comparative analysis. |
| Stock Ownership Guidelines | The company maintains meaningful stock ownership guidelines for its Chief Executive Officer and Chairman (6.0x Base Salary), Other Executive Officers (3.0x Base Salary), and Non-Employee Directors (3.0x Annual Cash Retainer), with a five-year period to meet these requirements. | N/A | Aims to reinforce the importance of stock ownership and align the long-term interests of executives and directors with those of stockholders. |
| Prohibition on Pledging and Hedging | The company's insider trading policy prohibits officers, directors, and associates from pledging company securities, holding them in margin accounts, or engaging in hedging, monetization, and similar transactions. | N/A | Ensures that the interests of these individuals remain aligned with those of stockholders and discourages speculative or risk-mitigating trading that could signal a lack of confidence. |
| Section 16(a) Reporting Delinquencies | Several directors (Messrs. Lukash, Celia, Dhaliwal, Schwartz, and Seelenfreund) did not timely file one Form 3 for fiscal year 2024. | N/A | Indicates a lapse in compliance with regulatory reporting requirements for initial ownership of company securities, which could raise concerns about internal controls or oversight. |
Related Party Transactions
- An amount of $128,000 was due to Emory S. De Castro (Chief Technology Officer and Director) as of December 31, 2024, and September 19, 2025.
Stakeholder Impact
- Shareholders face potential significant dilution from the proposed $52,000,000 stock issuance to Hudson Global Ventures, LLC, which could impact stock price and voting power.
- Employees, particularly executives and non-employee directors, are impacted by the proposed amendment to the 2021 Incentive Plan, which aims to enhance their equity compensation opportunities and retention.
- Executive officers have deferred compensation payments beginning June 2024, which are recorded as accrued liabilities, potentially impacting their personal financial planning and morale.
- The termination for cause of the former CEO, Vassilios Gregoriou, and the appointment of Gary Herman, represent significant leadership changes that could affect company direction and employee confidence.
Next Steps
- Stockholders will vote on the seven proposals at the Annual Meeting on October 22, 2025.
- The company will elect three Class II directors to serve until the 2027 annual meeting.
- The appointment of M&K CPAS, PLLC as the independent registered public accounting firm for fiscal year 2025 will be ratified.
- Subject to stockholder approval, the company may issue and sell additional Common Stock to Hudson Global Ventures, LLC, up to $52,000,000.
- Subject to stockholder approval, the 2021 Incentive Plan will be amended to increase authorized shares and incorporate an Evergreen Provision.
- The Board will consider the results of the non-binding advisory votes on executive compensation and its frequency.
- Annual increases under the Incentive Plan's Evergreen Provision are scheduled to begin on January 1, 2027, and end on January 1, 2046.
Key Dates
| Date | Description |
|---|---|
| 2020-10-12 | Advent entered into employment agreements with Dr. Gregoriou and Mr. Coffey. |
| 2021-02-01 | Advent Technologies Holdings, Inc. 2021 Incentive Plan adopted. |
| 2021-02-04 | Vesting commencement date for certain option and stock awards. |
| 2021-06-11 | Compensation committee made grants to select senior executives following the Business Combination. |
| 2022-07-01 | Compensation committee granted a one-time special award to Dr. Gregoriou. |
| 2023-06-28 | Company granted 1,667 restricted stock units to each non-employee director. |
| 2024-01-01 | Start of period for related party transactions. |
| 2024-04-29 | Stockholders approved an amendment to the 2021 Equity Incentive Plan. |
| 2024-06-01 | Executive officers elected to forgo compensation payments beginning this month. |
| 2024-07-26 | Company granted 5,747 restricted stock units to each current serving non-employee director. |
| 2024-08-01 | Gary Herman became a director of Advent. |
| 2024-08-30 | Anggelos Skutaris, Lawrence Epstein, Wayne Threatt, and Von McConnell no longer served as non-employee directors. |
| 2024-10-01 | Gary Herman became Chief Executive Officer and Interim Chief Financial Officer of the Company. |
| 2024-10-24 | Dr. Gregoriou was terminated for cause from his position as Chief Executive Officer. |
| 2024-12-31 | Fiscal year end for financial statements. |
| 2025-08-14 | Company entered into a purchase agreement with Hudson Global Ventures, LLC. |
| 2025-09-02 | Deadline for stockholder proposals for 2026 proxy materials (Rule 14a-8). |
| 2025-09-19 | Record date for the 2025 Annual Meeting. |
| 2025-09-20 | Audit committee approved the engagement of M&K CPAS, PLLC for the fiscal year ending December 31, 2025. |
| 2025-09-25 | Closing sale price of Common Stock on Nasdaq was $3.38 per share. |
| 2025-09-29 | Board approved the Second Incentive Plan Amendment (subject to stockholder approval) and mailing of proxy materials commenced. |
| 2025-10-21 | Deadline for internet and telephone voting (11:59 p.m. Eastern Time). |
| 2025-10-22 | 2025 Annual Meeting of Stockholders at 9:00 a.m. Eastern Time. |
| 2025-11-01 | Deadline for notice for universal proxy rules (Rule 14a-19) for 2026 annual meeting. |
| 2026-10-21 | Webcast replay of 2025 Annual Meeting available until this date or the date of the next annual meeting. |
| 2026-09-02 | Earliest date for stockholder notice for 2026 annual meeting nominations/proposals (Bylaws). |
| 2026-10-02 | Latest date for stockholder notice for 2026 annual meeting nominations/proposals (Bylaws). |
| 2027-01-01 | Start date for annual increases under the Incentive Plan's Evergreen Provision. |
| 2046-01-01 | End date for annual increases under the Incentive Plan's Evergreen Provision. |
Recommendation
holdThe company is taking necessary steps to address its capital needs through a significant stock issuance and is working to retain talent via an expanded incentive plan. These are positive actions for the company's long-term viability. However, the substantial dilution required for the capital raise, coupled with a history of net losses and no gross profit, indicates significant financial challenges and uncertainty. The termination of the former CEO for cause and deferred executive compensation also raise concerns. Investors should hold to observe the impact of the capital raise and the company's ability to achieve profitability and manage dilution effectively before making further investment decisions.
Keywords
Advent Technologies, SEC filing, DEF 14A, Proxy Statement, Stockholder Meeting, Capital Raise, Equity Issuance, Incentive Plan, Executive Compensation, Corporate Governance, Nasdaq Listing Rule 5635(d), Hudson Global Ventures, Fuel Cell, Technology, Dilution, Stock Options, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.